TRIFEXIS DIN 02375494
Health Canada record
| Active ingredient(s) | SPINOSAD 810 MG; MILBEMYCIN OXIME 13.5 MG |
|---|---|
| Dosage form | Tablet (Chewable) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 07-Feb-2012 |
| Current status date | 30-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SPINOSAD
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02332493 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 140 MG | Cancelled Post Market |
| 02332507 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 270 MG | Cancelled Post Market |
| 02332515 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 560 MG | Cancelled Post Market |
| 02332523 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 810 MG | Cancelled Post Market |
| 02332531 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 1620 MG | Cancelled Post Market |
| 02393115 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 90 MG | Cancelled Post Market |
| 02375478 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 270 MG; MILBEMYCIN OXIME 4.5 MG | Cancelled Post Market |
| 02375486 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 560 MG; MILBEMYCIN OXIME 9.3 MG | Cancelled Post Market |
| 02375524 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 1620 MG; MILBEMYCIN OXIME 27 MG | Cancelled Post Market |
| 02375451 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | SPINOSAD 140 MG; MILBEMYCIN OXIME 2.3 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23284 | 2018-10-02 | Supplement to a New Drug Submission (SNDS) | ADDITION OF A DRUG SUBSTANCE MANUFACTURER |
| 20672 | 2018-03-28 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 17467 | 2015-11-12 | Supplement to a New Drug Submission (SNDS) | LABELLING UPDATE |
| 12745 | 2011-11-01 | New Drug Submission (NDS) |
International API supply for SPINOSAD
5 active FDA Drug Master Files.
Request a quote for TRIFEXIS